A systematic review of medical treatments for aortic stenosis evaluated lipid-lowering, antihypertensive, and anticalcific therapies aimed at halting disease progression.
Systematic Review
Untreated, severe, symptomatic aortic stenosis is associated with a dismal prognosis. The only treatment shown to improve survival is aortic valve replacement; however, before symptoms occur, aortic stenosis is preceded by a silent, latent phase characterized by a slow progression at the molecular, cellular, and tissue levels. In theory, specific medical therapy should halt aortic stenosis progression, reduce its hemodynamic repercussions on left ventricular function and remodeling, and improve clinical outcomes. In the present report, we performed a systematic review of studies focusing on the medical treatment of patients with aortic stenosis. Lipid-lowering therapy, antihypertensive drugs, and anticalcific therapy have been the main drug classes studied in this setting and are reviewed in depth. A critical appraisal of the preclinical and clinical evidence is provided, and future research avenues are presented.
Building similarity graph...
Analyzing shared references across papers
Loading...
Circulation
Sahlgrenska University Hospital
Cardiovascular Research Foundation
Hôpital du Sacré-Cœur de Montréal
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Marquis‐Gravel et al. (Mon,) conducted a systematic review in Aortic stenosis. Medical treatment (lipid-lowering therapy, antihypertensive drugs, anticalcific therapy) was evaluated. A systematic review of medical treatments for aortic stenosis evaluated lipid-lowering, antihypertensive, and anticalcific therapies aimed at halting disease progression.